Torigen Pharmaceuticals, based in Farmington, CT, is a leading brand focused on providing advanced cancer care solutions for companion animals. Comprised of a team of dedicated cancer researchers, veterinarians, and veterinary professionals, Torigen combines science, technology, and a passion for pets to extend the lives of companion animals diagnosed with cancer. The company's product, an experimental autologous cancer vaccine, is based on the groundbreaking research of Dr.

Mark Suckow, a renowned professor and Associate Vice President of Research at the University of Kentucky. Torigen also boasts a team of experts, including Chief Executive Officer Ashley Kalinauskas, Chief Medical Officer Dr. Michael Lucroy, and VP of Research and Development Dr.

Ryan Clauson, who bring extensive experience in veterinary medicine, immunology, and pharmaceutical science. With a focus on innovation, Torigen is constantly evaluating new technologies and expanding its pipeline to make a difference in veterinary medicine. For veterinarians and pet owners seeking the most effective cancer care solutions, Torigen Pharmaceuticals is the trusted choice.

Contact Torigen today to learn more and order a kit